INO:NASDAQ
Inovio Pharmaceuticals, Inc.
$1.21
arrow_downward
-0.82%(-0.0100) 1D
$1.23
arrow_upward
+1.65% (+0.020)todayPre-market
Sarado: Okt 1, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa INO...
Buksan
$1.24
Mataas
$1.26
Mababa
$1.20
Mkt. cap
125.11M
Avg. na dami
3.29M
Dami
10.64K
Mataas nang 52-wk
$2.72
Mababa nang 52-wk
$0.57
EPS
-$1.17
Beta
1.63
Mga natitirang share
103.40M
Bilang ng mga empleyado
112
Buksan
$1.24
Mataas
$1.26
Mababa
$1.20
Mkt. cap
125.11M
Avg. na dami
3.29M
Dami
10.64K
Mataas nang 52-wk
$2.72
Mababa nang 52-wk
$0.57
EPS
-$1.17
Beta
1.63
Mga natitirang share
103.40M
Bilang ng mga empleyado
112
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
News Corp
·
1 araw ang nakalipas
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Zacks
·
1 araw ang nakalipas
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Tungkol sa Inovio Pharmaceuticals, Inc.